FEMOFLORA AND ITS USE IN WOMEN WITH CERVICAL NEOPLASIA IN THE DYNAMICS OF TRADITIONAL AND NEW TREATMENTS

Abstract

Current evidence suggests that a significant proportion of cervical diseases are associated with the presence of human papillomavirus. The papillomavirus infection is characterised by a high prevalence, a high capacity for transmission and a pronounced oncogenic potential. The infection rate of the sexually active population of the world ranges from 20 to 60%. The real incidence of papillomavirus infection cannot be assessed at the moment as there are no measures for mandatory reporting. PCR is the most sensitive and specific method, based on the identification and quantification of genome fragments. It is an instrumental technique, so the risk of incorrect, subjective assessment of test results related to staff qualifications is minimised. As PCR is not a cultivation technique, stringent requirements to preserve the viability of microorganisms before biomaterial enters the laboratory and the technical capacity of a laboratory tank to cultivate strict anaerobic microorganisms are irrelevant in the case of PCR.